Iron metabolism in the anemia of chronic disease

Biochimica et Biophysica Acta - General Subjects

Volumn 1790, Issue 7, 2009, Pages 682-693

  Weiss, Günter ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cytokine; Ferroportin; Hepcidin; Infection; Iron restriction; Macrophage

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; DEFEROXAMINE; FERROPORTIN; HEPCIDIN; IRON;

ANEMIA; ANEMIA OF CHRONIC DISEASE; CIRCULATION; DISEASE MODEL; ERYTHROPHAGOCYTOSIS; ERYTHROPOIESIS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; IRON DEFICIENCY; IRON METABOLISM; MACROPHAGE; MALARIA FALCIPARUM; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; RNA TRANSLATION;

ANEMIA; CHRONIC DISEASE; HOMEOSTASIS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; IRON; MACROPHAGES; MONOCYTES; RECEPTORS, TRANSFERRIN;

EID: 67349115201     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2008.08.006     Document Type: Review

References (269)

1. Weiss G., and Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 352 (2005) 1011-1023
2. Cartwright G.E. The anemia of chronic disorders. Semin. Hematol. 3 (1966) 351-375
3. Matzner Y., Levy S., Grossowicz N., Izak G., and Hershko C. Prevalence and causes of anemia in elderly hospitalized patients. Gerontology 25 (1979) 113-119
4. Weiss G. Pathogenesis and treatment of anaemia of chronic disease. Blood Rev. 16 (2002) 87-96
5. Means Jr. R.T. Recent developments in the anemia of chronic disease. Curr. Hematol. Rep. 2 (2003) 116-121
6. Spivak J.L. Iron and the anemia of chronic disease. Oncology (Huntingt) 16 (2002) 25-33
7. Goodnough L.T., Dubois R.W., and Nissenson A.R. Anemia: not just an innocent bystander?. Arch. Intern. Med. 163 (2003) 1820-1822
8. Harrison L., Shasha D., Shiaova L., White C., Ramdeen B., and Portenoy R. Prevalence of anemia in cancer patients undergoing radiation therapy. Semin. Oncol. 28 (2001) 54-59
9. Dunn A., Carter J., and Carter H. Anemia at the end of life: prevalence, significance, and causes in patients receiving palliative care. J. Pain Symp. Manag. 26 (2003) 1132-1139
10. Gasche C., Lomer M.C., Cavill I., and Weiss G. Iron, anaemia, and inflammatory bowel diseases. Gut 53 (2004) 1190-1197
11. Sullivan P.S., Hanson D.L., Chu S.Y., Jones J.L., and Ward J.W. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 91 (1998) 301-308
12. Fuchs D., Zangerle R., Artner-Dworzak E., Weiss G., Fritsch P., Tilz G.P., Dierich M.P., and Wachter H. Association between immune activation, changes of iron metabolism and anaemia in patients with HIV infection. Eur. J. Haematol. 50 (1993) 90-94
13. Maury C.P., Liljestrom M., Laiho K., Tiitinen S., Kaarela K., and Hurme M. Tumor necrosis factor alpha, its soluble receptor I, and -308 gene promoter polymorphism in patients with rheumatoid arthritis with or without amyloidosis: implications for the pathogenesis of nephropathy and anemia of chronic disease in reactive amyloidosis. Arthritis Rheum. 48 (2003) 3068-3076
14. Denz H., Huber P., Landmann R., Orth B., Wachter H., and Fuchs D. Association between the activation of macrophages, changes of iron metabolism and the degree of anaemia in patients with malignant disorders. Eur. J. Haematol. 48 (1992) 244-248
15. Santoro A. Anemia in renal insufficiency. Rev. Clin. Exp. Hematol. Suppl. 1 (2002) 12-20
16. Eschbach J.W. Anemia management in chronic kidney disease: role of factors affecting epoetin responsiveness. J. Am. Soc. Nephrol. 13 (2002) 1412-1414
17. Weiss G., Meusburger E., Radacher G., Garimorth K., Neyer U., and Mayer G. Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human erythropoietin. Kidney Int. 64 (2003) 572-578
18. Walsh T.S., and Saleh E.E. Anaemia during critical illness. Br. J. Anaesth. 97 (2006) 278-291
19. van Iperen C.E., van de Wiel A., and Marx J.J. Acute event-related anaemia. Br. J. Haematol. 115 (2001) 739-743
20. Munoz M., Romero A., Morales M., Campos A., Garcia-Erce J.A., and Ramirez G. Iron metabolism, inflammation and anemia in critically ill patients. A cross-sectional study. Nutr. Hosp. 20 (2005) 115-120
21. Patteril M.V., Davey-Quinn A.P., Gedney J.A., Murdoch S.D., and Bellamy M.C. Functional iron deficiency, infection and systemic inflammatory response syndrome in critical illness. Anaesth. Intensive Care 29 (2001) 473-478
22. Rogiers P., Zhang H., Leeman M., Nagler J., Neels H., Melot C., and Vincent J.L. Erythropoietin response is blunted in critically ill patients. Intensive Care Med. 23 (1997) 159-162
23. Wang C.Q., Udupa K.B., and Lipschitz D.A. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development. J. Cell Physiol. 162 (1995) 134-138
24. Taniguchi S., Dai C.H., Price J.O., and Krantz S.B. Interferon gamma downregulates stem cell factor and erythropoietin receptors but not insulin-like growth factor-I receptors in human erythroid colony-forming cells. Blood 90 (1997) 2244-2252
25. Maciejewski J.P., Selleri C., Sato T., Cho H.J., Keefer L.K., Nathan C.F., and Young N.S. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha. J. Clin. Investig. 96 (1995) 1085-1092
26. Graziadei I., Gaggl S., Kaserbacher R., Braunsteiner H., and Vogel W. The acute-phase protein alpha 1-antitrypsin inhibits growth and proliferation of human early erythroid progenitor cells (burst-forming units-erythroid) and of human erythroleukemic cells (K562) in vitro by interfering with transferrin iron uptake. Blood 83 (1994) 260-268
27. Weiss G., Graziadel I., Urbanek M., Grunewald K., and Vogel W. Divergent effects of alpha 1-antitrypsin on the regulation of iron metabolism in human erythroleukaemic (K562) and myelomonocytic (THP-1) cells. Biochem. J. 319 Pt 3 (1996) 897-902
28. Broxmeyer H.E. H-ferritin: a regulatory cytokine that down-modulates cell proliferation. J. Lab. Clin. Med. 120 (1992) 367-370
29. Rodriguez R.M., Corwin H.L., Gettinger A., Corwin M.J., Gubler D., and Pearl R.G. Nutritional deficiencies and blunted erythropoietin response as causes of the anemia of critical illness. J. Crit. Care 16 (2001) 36-41
30. Groopman J.E., and Itri L.M. Chemotherapy-induced anemia in adults: incidence and treatment. J. Natl. Cancer Inst. 91 (1999) 1616-1634
31. Miller C.B., Jones R.J., Piantadosi S., Abeloff M.D., and Spivak J.L. Decreased erythropoietin response in patients with the anemia of cancer. N. Engl. J. Med. 322 (1990) 1689-1692
32. Cazzola M., Ponchio L., de Benedetti F., Ravelli A., Rosti V., Beguin Y., Invernizzi R., Barosi G., and Martini A. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood 87 (1996) 4824-4830
33. Theurl I., Mattle V., Seifert M., Mariani M., Marth C., and Weiss G. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood 107 (2006) 4142-4148
34. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J. Interferon. Cytokine Res. 18 (1998) 555-559
35. Means Jr. R.T., and Krantz S.B. Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood 78 (1991) 2564-2567
36. Minoo P., Zadeh M.M., Rottapel R., Lebrun J.J., and Ali S. A novel SHP-1/Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signaling. Blood 103 (2004) 1398-1407
37. Metzen E., and Jelkmann W. Erythropoietin and erythropoiesis. In: Weiss G., Gordeuk V., and Hershko C. (Eds). Anemia of Chronic Disease (2005), Taylor and Francis, New York 61-86
38. Hershko C., Ronson A., Souroujon M., Maschler Z., Heyd J., and Patz J. Variable hematological presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood 107 (2006) 1673-1679
39. Yap G.S., and Stevenson M.M. Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumor necrosis factor alpha, and gamma interferon. Infect. Immun. 62 (1994) 357-362
40. Oppenheimer S.J. Iron and its relation to immunity and infectious disease. J. Nutr. 131 (2001) 616S-633S discussion 633S-635S
41. Deicher R., and Horl W.H. Anaemia as a risk factor for the progression of chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 12 (2003) 139-143
42. Wessling-Resnick M. Iron imports. III. Transfer of iron from the mucosa into circulation. Am. J. Physiol. Gastrointest.: Liver Physiol. 290 (2006) G1-6
43. Frazer D.M., and Anderson G.J. The orchestration of body iron intake: how and where do enterocytes receive their cues?. Blood Cells Mol. Dis. 30 (2003) 288-297
44. Schumann K., Moret R., Kunzle H., and Kuhn L.C. Iron regulatory protein as an endogenous sensor of iron in rat intestinal mucosa. Possible implications for the regulation of iron absorption. Eur. J. Biochem. 260 (1999) 362-372
45. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
46. Brissot P., Troadec M.B., and Loreal O. The clinical relevance of new insights in iron transport and metabolism. Curr. Hematol. Rep. 3 (2004) 107-115
47. Moura E., Noordermeer M.A., Verhoeven N., Verheul A.F., and Marx J.J. Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood 92 (1998) 2511-2519
48. Knutson M.D., Oukka M., Koss L.M., Aydemir F., and Wessling-Resnick M. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1324-1328
49. Andrews N.C. Anemia of inflammation: the cytokine-hepcidin link. J. Clin. Invest. 113 (2004) 1251-1253
50. Rosen G.M., Pou S., Ramos C.L., Cohen M.S., and Britigan B.E. Free radicals and phagocytic cells. FASEB J. 9 (1995) 200-209
51. Le N.T., and Richardson D.R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 1603 (2002) 31-46
52. Oexle H., Gnaiger E., and Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim. Biophys. Acta 1413 (1999) 99-107
53. Weiss G. Iron acquisition by the reticuloendothelial system. In: Templeton D. (Ed). Molecular and Cellular Iron Transport (2002), Marcel Dekker Inc., New York 467-488
54. Fahmy M., and Young S.P. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochemical. J. 296 Pt 1 (1993) 175-181
55. Ohgami R.S., Campagna D.R., Greer E.L., Antiochos B., McDonald A., Chen J., Sharp J.J., Fujiwara Y., Barker J.E., and Fleming M.D. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat. Genet. 37 (2005) 1264-1269
56. Fleming M.D., Trenor III C.C., Su M.A., Foernzler D., Beier D.R., Dietrich W.F., and Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16 (1997) 383-386
57. Dautry-Varsat A., Ciechanover A., and Lodish H.F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 2258-2262
58. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997) 482-488
59. Mims M.P., and Prchal J.T. Divalent metal transporter 1. Hematology 10 (2005) 339-345
60. Mackenzie B., and Garrick M.D. Iron imports. II. Iron uptake at the apical membrane in the intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 289 (2005) G981-986
61. Koch R.O., Zoller H., Theuri I., Obrist P., Egg G., Strohmayer W., Vogel W., and Weiss G. Distribution of DMT 1 within the human glandular system. Histol. Histopathol. 18 (2003) 1095-1101
62. Canonne-Hergaux F., and Gros P. Expression of the iron transporter DMT1 in kidney from normal and anemic mk mice. Kidney Int. 62 (2002) 147-156
63. Ludwiczek S., Theurl I., Muckenthaler M.U., Jakab M., Mair S.M., Theurl M., Kiss J., Paulmichl M., Hentze M.W., Ritter M., and Weiss G. Ca(2+) channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1. Nat. Med. 13 (2007) 448-454
64. Ferguson C.J., Wareing M., Ward D.T., Green R., Smith C.P., and Riccardi D. Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am. J. Physiol. Renal. Physiol. 280 (2001) F803-814
65. Andrews N.C. The iron transporter DMT1. Int. J. Biochem. Cell Biol. 31 (1999) 991-994
66. Hubert N., and Hentze M.W. Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: implications for regulation and cellular function. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 12345-12350
67. Mackenzie B., Takanaga H., Hubert N., Rolfs A., and Hediger M.A. Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochemical. J. 403 (2007) 59-69
68. Lam-Yuk-Tseung S., and Gros P. Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2 Slc11A2). Biochemistry 45 (2006) 2294-2301
69. Abouhamed M., Gburek J., Liu W., Torchalski B., Wilhelm A., Wolff N.A., Christensen E.I., Thevenod F., and Smith C.P. Divalent metal transporter 1 in the kidney proximal tubule is expressed in late endosomes/lysosomal membranes: implications for renal handling of protein-metal complexes. Am. J. Physiol. Renal. Physiol. 290 (2006) F1525-1533
70. Lam-Yuk-Tseung S., Touret N., Grinstein S., and Gros P. Carboxyl-terminus determinants of the iron transporter DMT1/SLC11A2 isoform II (-IRE/1B) mediate internalization from the plasma membrane into recycling endosomes. Biochemistry 44 (2005) 12149-12159
71. McKie A.T., Barrow D., Latunde-Dada G.O., Rolfs A., Sager G., Mudaly E., Mudaly M., Richardson C., Barlow D., Bomford A., Peters T.J., Raja K.B., Shirali S., Hediger M.A., Farzaneh F., and Simpson R.J. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291 (2001) 1755-1759
72. Arosio P., and Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic. Biol. Med. 33 (2002) 457-463
73. Torti F.M., and Torti S.V. Regulation of ferritin genes and protein. Blood 99 (2002) 3505-3516
74. Kakhlon O., and Cabantchik Z.I. The labile iron pool: characterization, measurement, and participation in cellular processes (1). Free Radic. Biol. Med. 33 (2002) 1037-1046
75. Olakanmi O., Stokes J.B., and Britigan B.E. Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages. J. Immunol. 153 (1994) 2691-2703
76. Ludwiczek S., Aigner E., Theurl I., and Weiss G. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood 101 (2003) 4148-4154
77. Oudit G.Y., Sun H., Trivieri M.G., Koch S.E., Dawood F., Ackerley C., Yazdanpanah M., Wilson G.J., Schwartz A., Liu P.P., and Backx P.H. L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9 (2003) 1187-1194
78. Moss D., Fargion S., Fracanzani A.L., Levi S., Cappellini M.D., Arosio P., Powell L.W., and Halliday J.W. Functional roles of the ferritin receptors of human liver, hepatoma, lymphoid and erythroid cells. J. Inorg. Biochem. 47 (1992) 219-227
79. Fisher J., Devraj K., Ingram J., Slagle-Webb B., Madhankumar A.B., Liu X., Klinger M., Simpson I.A., and Connor J.R. Ferritin: a novel mechanism for delivery of iron to the brain and other organs. Am. J. Physiol. Cell Physiol. 293 (2007) C641-649
80. Leimberg M.J., Prus E., Konijn A.M., and Fibach E. Macrophages function as a ferritin iron source for cultured human erythroid precursors. J. Cell Biochem. 103 (2008) 1211-1218
81. Brock J.H. The physiology of lactoferrin. Biochem. Cell Biol. 80 (2002) 1-6
82. Crouch S.P., Slater K.J., and Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80 (1992) 235-240
83. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., and Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 409 (2001) 198-201
84. Graversen J.H., Madsen M., and Moestrup S.K. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int. J. Biochem. Cell Biol. 34 (2002) 309-314
85. Schaer D.J., Schaer C.A., Buehler P.W., Boykins R.A., Schoedon G., Alayash A.I., and Schaffner A. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107 (2006) 373-380
86. Hvidberg V., Maniecki M.B., Jacobsen C., Hojrup P., Moller H.J., and Moestrup S.K. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106 (2005) 2572-2579
87. Poss K.D., and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10919-10924
88. Bach F.H. Heme oxygenase-1: a therapeutic amplification funnel. FASEB J. 19 (2005) 1216-1219
89. Kitagawa S., Yuo A., Yagisawa M., Azuma E., Yoshida M., Furukawa Y., Takahashi M., Masuyama J., and Takaku F. Activation of human monocyte functions by tumor necrosis factor: rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. Exp. Hematol. 24 (1996) 559-567
90. Zuckerbraun B.S., and Billiar T.R. Heme oxygenase-1: a cellular Hercules. Hepatology 37 (2003) 742-744
91. Nairz M., and Weiss G. Molecular and clinical aspects of iron homeostasis: from anemia to hemochromatosis. Wien. Klin. Wochenschr. 118 (2006) 442-462
92. Eisenstein R.S., and Ross K.L. Novel roles for iron regulatory proteins in the adaptive response to iron deficiency. J. Nutr. 133 (2003) 1510S-1516S
93. Rouault T., and Klausner R. Regulation of iron metabolism in eukaryotes. Curr. Top. Cell Regul. 35 (1997) 1-19
94. Andrews N.C., and Schmidt P.J. Iron homeostasis. Annu. Rev. Physiol. 69 (2007) 69-85
95. Muckenthaler M., Gray N.K., and Hentze M.W. IRP-1 binding to ferritin mRNA prevents the recruitment of the small ribosomal subunit by the cap-binding complex eIF4F. Mol. Cell 2 (1998) 383-388
96. Haile D.J., Rouault T.A., Tang C.K., Chin J., Harford J.B., and Klausner R.D. Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 7536-7540
97. Rouault T.A. The role of iron regulatory proteins in mammalian iron homeostasis and disease. Nat. Chem. Biol. 2 (2006) 406-414
98. Yamanaka K., Ishikawa H., Megumi Y., Tokunaga F., Kanie M., Rouault T.A., Morishima I., Minato N., Ishimori K., and Iwai K. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5 (2003) 336-340
99. Hanson E.S., Rawlins M.L., and Leibold E.A. Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278 (2003) 40337-40342
100. Weiss G., Goossen B., Doppler W., Fuchs D., Pantopoulos K., Werner-Felmayer G., Wachter H., and Hentze M.W. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 12 (1993) 3651-3657
101. Drapier J.C., Hirling H., Wietzerbin J., Kaldy P., and Kuhn L.C. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J. 12 (1993) 3643-3649
102. Pantopoulos K., and Hentze M.W. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 14 (1995) 2917-2924
103. Schneider B.D., and Leibold E.A. Effects of iron regulatory protein regulation on iron homeostasis during hypoxia. Blood 102 (2003) 3404-3411
104. Cairo G., Recalcati S., Pietrangelo A., and Minotti G. The iron regulatory proteins: targets and modulators of free radical reactions and oxidative damage. Free Rad. Biol. Med. 32 (2002) 1237-1243
105. Leipuviene R., and Theil E.C. The family of iron responsive RNA structures regulated by changes in cellular iron and oxygen. Cell Mol. Life. Sci. 64 (2007) 2945-2955
106. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo Jr. R., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., Kimmel B.E., Kronmal G.S., Lauer P., Lee V.K., Loeb D.B., Mapa F.A., McClelland E., Meyer N.C., Mintier G.A., Moeller N., Moore T., Morikang E., Wolff R.K., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13 (1996) 399-408
107. Anderson G.J., and Powell L.W. HFE and non-HFE hemochromatosis. Int. J. Hematol. 76 (2002) 203-207
108. Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N. Engl. J. Med. 350 (2004) 2383-2397
109. Rothenberg B.E., and Voland J.R. beta2 knockout mice develop parenchymal iron overload: A putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1529-1534
110. Santos M., Schilham M.W., Rademakers L.H., Marx J.J., de Sousa M., and Clevers H. Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J. Exp. Med. 184 (1996) 1975-1985
111. Lebron J.A., Bennett M.J., Vaughn D.E., Chirino A.J., Snow P.M., Mintier G.A., Feder J.N., and Bjorkman P.J. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93 (1998) 111-123
112. Parkkila S., Waheed A., Britton R.S., Bacon B.R., Zhou X.Y., Tomatsu S., Fleming R.E., and Sly W.S. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 13198-13202
113. Ludwiczek S., Theurl I., Artner-Dworzak E., Chorney M., and Weiss G. Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability. J. Mol. Med. 82 (2004) 373-382
114. Fleming R.E., and Sly W.S. Mechanisms of iron accumulation in hereditary hemochromatosis. Annu. Rev. Physiol. 64 (2002) 663-680
115. Ten Elshof A.E., Brittenham G.M., Chorney K.A., Page M.J., Gerhard G., Cable E.E., and Chorney M.J. Gamma delta intraepithelial lymphocytes drive tumor necrosis factor-alpha responsiveness to intestinal iron challenge: relevance to hemochromatosis. Immunol. Rev. 167 (1999) 223-232
116. Drakesmith H., Sweetland E., Schimanski L., Edwards J., Cowley D., Ashraf M., Bastin J., and Townsend A.R. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 15602-15607
117. Montosi G., Paglia P., Garuti C., Guzman C.A., Bastin J.M., Colombo M.P., and Pietrangelo A. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood 96 (2000) 1125-1129
118. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am. J. Physiol. Gastrointest.: Liver Physiol. 282 (2002) G403-414
119. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentze M.W., and Simpson R.J. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5 (2000) 299-309
120. Yang F., Liu X.B., Quinones M., Melby P.C., Ghio A., and Haile D.J. Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation. J. Biol. Chem. 277 (2002) 39786-39791
121. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C., Lux S.E., Pinkus G.S., Pinkus J.L., Kingsley P.D., Palis J., Fleming M.D., Andrews N.C., and Zon L.I. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
122. Pietrangelo A. Hemochromatosis: an endocrine liver disease. Hepatology 46 (2007) 1291-1301
123. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., Gitschier J., and Anderson G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21 (1999) 195-199
124. Knutson M.D., Vafa M.R., Haile D.J., and Wessling-Resnick M. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 102 (2003) 4191-4197
125. Delaby C., Pilard N., Puy H., and Canonne-Hergaux F. Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem. J. 411 (2008) 123-131
126. Ganz T., and Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am. J. Physiol. Gastrointest.: Liver Physiol. 290 (2006) G199-203
127. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., Sirito M., Sawadogo M., Kahn A., and Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4596-4601
128. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276 (2001) 7811-7819
129. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
130. De Domenico I., Ward D.M., Langelier C., Vaughn M.B., Nemeth E., Sundquist W.I., Ganz T., Musci G., and Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18 (2007) 2569-2578
131. Delaby C., Pilard N., Goncalves A.S., Beaumont C., and Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 106 (2005) 3979-3984
132. Roy C.N., Mak H.H., Akpan I., Losyev G., Zurakowski D., and Andrews N.C. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109 (2007) 4038-4044
133. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8780-8785
134. Laftah A.H., Ramesh B., Simpson R.J., Solanky N., Bahram S., Schumann K., Debnam E.S., and Srai S.K. Effect of hepcidin on intestinal iron absorption in mice. Blood 103 (2004) 3940-3944
135. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., and Andrews N.C. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1 (2005) 191-200
136. Ludwiczek S., Theurl I., Bahram S., Schumann K., and Weiss G. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis. J. Cell Physiol. 204 (2005) 489-499
137. Muckenthaler M., Roy C.N., Custodio A.O., Minana B., deGraaf J., Montross L.K., Andrews N.C., and Hentze M.W. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34 (2003) 102-107
138. Bridle K.R., Frazer D.M., Wilkins S.J., Dixon J.L., Purdie D.M., Crawford D.H., Subramaniam V.N., Powell L.W., Anderson G.J., and Ramm G.A. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361 (2003) 669-673
139. Ahmad K.A., Ahmann J.R., Migas M.C., Waheed A., Britton R.S., Bacon B.R., Sly W.S., and Fleming R.E. Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29 (2002) 361-366
140. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., Loukopoulos D., and Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33 (2003) 21-22
141. Lesbordes-Brion J.C., Viatte L., Bennoun M., Lou D.Q., Ramey G., Houbron C., Hamard G., Kahn A., and Vaulont S. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108 (2006) 1402-1405
142. Keel S.B., Doty R.T., Yang Z., Quigley J.G., Chen J., Knoblaugh S., Kingsley P.D., De Domenico I., Vaughn M.B., Kaplan J., Palis J., and Abkowitz J.L. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 319 (2008) 825-828
143. Quigley J.G., Yang Z., Worthington M.T., Phillips J.D., Sabo K.M., Sabath D.E., Berg C.L., Sassa S., Wood B.L., and Abkowitz J.L. Identification of a human heme exporter that is essential for erythropoiesis. Cell 118 (2004) 757-766
144. De Domenico I., Ward D.M., di Patti M.C., Jeong S.Y., David S., Musci G., and Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26 (2007) 2823-2831
145. Wang F., Paradkar P.N., Custodio A.O., McVey Ward D., Fleming M.D., Campagna D., Roberts K.A., Boyartchuk V., Dietrich W.F., Kaplan J., and Andrews N.C. Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice. Nat. Genet. 39 (2007) 1025-1032
146. Weiss G. Iron and immunity: a double-edged sword. Eur. J. Clin. Invest. 32 Suppl 1 (2002) 70-78
147. Knutson M., and Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38 (2003) 61-88
148. Theurl I., Fritsche G., Ludwiczek S., Garimorth K., Bellmann-Weiler R., and Weiss G. The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals 18 (2005) 359-367
149. Weiss G. Modification of iron regulation by the inflammatory response. Best Pract. Res., Clin. Haematol. 18 (2005) 183-201
150. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
151. Thomas C., and Thomas L. Anemia of chronic disease: pathophysiology and laboratory diagnosis. Lab. Hematol. 11 (2005) 14-23
152. Porto G., and De Sousa M. Iron overload and immunity. World J. Gastroenterol. 13 (2007) 4707-4715
153. Mastroeni P., Vazquez-Torres A., Fang F.C., Xu Y., Khan S., Hormaeche C.E., and Dougan G. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192 (2000) 237-248
154. Schaible U.E., and Kaufmann S.H. Iron and microbial infection. Nat. Rev. Microbiol. 2 (2004) 946-953
155. Weinberg E.D. Iron loading and disease surveillance. Emerg. Infect. Dis. 5 (1999) 346-352
156. Walter T., Olivares M., Pizarro F., and Munoz C. Iron, anemia, and infection. Nutr. Rev. 55 (1997) 111-124
157. Weiss G. [Iron, infection and anemia-a classical triad]. Wien. Klin. Wochenschr. 114 (2002) 357-367
158. Forbes J.R., and Gros P. Divalent-metal transport by NRAMP proteins at the interface of host-pathogen interactions. Trends Microbiol. 9 (2001) 397-403
159. Blackwell J.M., Searle S., Goswami T., and Miller E.N. Understanding the multiple functions of Nramp1. Microbes. Infect. 2 (2000) 317-321
160. Kuhn D.E., Lafuse W.P., and Zwilling B.S. Iron transport into mycobacterium avium-containing phagosomes from an Nramp1(Gly169)-transfected RAW264.7 macrophage cell line. J. Leukoc. Biol. 69 (2001) 43-49
161. Fritsche G., Nairz M., Theurl I., Mair S., Bellmann-Weiler R., Barton H.C., and Weiss G. Modulation of macrophage iron transport by Nramp1 (Slc11a1). Immunobiology 212 (2007) 751-757
162. Alter-Koltunoff M., Ehrlich S., Dror N., Azriel A., Eilers M., Hauser H., Bowen H., Barton C.H., Tamura T., Ozato K., and Levi B.Z. Nramp1-mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1, and Miz-1. J. Biol. Chem. 278 (2003) 44025-44032
163. Fritsche G., Dlaska M., Barton H., Theurl I., Garimorth K., and Weiss G. Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J. Immunol. 171 (2003) 1994-1998
164. Mulero V., Searle S., Blackwell J.M., and Brock J.H. Solute carrier 11a1 (Slc11a1; formerly Nramp1) regulates metabolism and release of iron acquired by phagocytic, but not transferrin-receptor-mediated, iron uptake. Biochem. J. 363 (2002) 89-94
165. Canonne-Hergaux F., Gruenheid S., Govoni G., and Gros P. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc. Assoc. Am. Physicians 111 (1999) 283-289
166. Jabado N., Jankowski A., Dougaparsad S., Picard V., Grinstein S., and Gros P. Natural resistance to intracellular infections: natural resistance-associated macrophage protein 1 (Nramp1) functions as a pH-dependent manganese transporter at the phagosomal membrane. J. Exp. Med. 192 (2000) 1237-1248
167. Baker S.T., Barton C.H., and Biggs T.E. A negative autoregulatory link between Nramp1 function and expression. J. Leukoc. Biol. 67 (2000) 501-507
168. Leggett B.A., Brown N.N., Bryant S.J., Duplock L., Powell L.W., and Halliday J.W. Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin. Chem. 36 (1990) 1350-1355
169. Konijn A.M., Carmel N., Levy R., and Hershko C. Ferritin synthesis in inflammation. II. Mechanism of increased ferritin synthesis. Br. J. Haematol. 49 (1981) 361-370
170. Alvarez-Hernandez X., Liceaga J., McKay I.C., and Brock J.H. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab. Invest. 61 (1989) 319-322
171. Wei Y., Miller S.C., Tsuji Y., Torti S.V., and Torti F.M. Interleukin 1 induces ferritin heavy chain in human muscle cells. Biochem. Biophys. Res. Commun. 169 (1990) 289-296
172. Byrd T.F., and Horwitz M.A. Regulation of transferrin receptor expression and ferritin content in human mononuclear phagocytes. Coordinate upregulation by iron transferrin and downregulation by interferon gamma. J. Clin. Invest. 91 (1993) 969-976
173. Moldawer L.L., Marano M.A., Wei H., Fong Y., Silen M.L., Kuo G., Manogue K.R., Vlassara H., Cohen H., Cerami A., et al. Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 3 (1989) 1637-1643
174. Mulero V., and Brock J.H. Regulation of iron metabolism in murine J774 macrophages: role of nitric oxide-dependent and -independent pathways following activation with gamma interferon and lipopolysaccharide. Blood 94 (1999) 2383-2389
175. Recalcati S., Taramelli D., Conte D., and Cairo G. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 91 (1998) 1059-1066
176. Pantopoulos K., and Hentze M.W. Nitric oxide signaling to iron-regulatory protein: direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 1267-1271
177. Bouton C., and Drapier J.C. Iron regulatory proteins as NO signal transducers. Sci. STKE. 2003 (2003) pe17
178. Bouton C., Oliveira L., and Drapier J.C. Converse modulation of IRP1 and IRP2 by immunological stimuli in murine RAW 264.7 macrophages. J. Biol. Chem. 273 (1998) 9403-9408
179. Hanson E.S., and Leibold E.A. Regulation of the iron regulatory proteins by reactive nitrogen and oxygen species. Gene Expr. 7 (1999) 367-376
180. Kim S., Wing S.S., and Ponka P. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol. Cell Biol. 24 (2004) 330-337
181. Caltagirone A., Weiss G., and Pantopoulos K. Modulation of cellular iron metabolism by hydrogen peroxide. Effects of H2O2 on the expression and function of iron-responsive element-containing mRNAs in B6 fibroblasts. J. Biol. Chem. 276 (2001) 19738-19745
182. Kim S., and Ponka P. Nitric oxide-mediated modulation of iron regulatory proteins: implication for cellular iron homeostasis. Blood Cells Mol. Dis. 29 (2002) 400-410
183. Richardson D.R., and Lok H.C. The nitric oxide-iron interplay in mammalian cells: transport and storage of dinitrosyl iron complexes. Biochim. Biophys. Acta 1780 (2008) 638-651
184. Wang J., Chen G., and Pantopoulos K. Nitric oxide inhibits the degradation of IRP2. Mol. Cell Biol. 25 (2005) 1347-1353
185. Wang J., Fillebeen C., Chen G., Andriopoulos B., and Pantopoulos K. Sodium nitroprusside promotes IRP2 degradation via an increase in intracellular iron and in the absence of S nitrosylation at C178. Mol. Cell Biol. 26 (2006) 1948-1954
186. Mikhael M., Kim S.F., Schranzhofer M., Soe-Lin S., Sheftel A.D., Mullner E.W., and Ponka P. Iron regulatory protein-independent regulation of ferritin synthesis by nitrogen monoxide. The FEBS J. 273 (2006) 3828-3836
187. Papanikolaou G., and Pantopoulos K. Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202 (2005) 199-211
188. Cairo G., Castrusini E., Minotti G., and Bernelli-Zazzera A. Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury. FASEB J. 10 (1996) 1326-1335
189. Gonzalez D., Drapier J.C., and Bouton C. Endogenous nitration of iron regulatory protein-1 (IRP-1) in nitric oxide-producing murine macrophages: further insight into the mechanism of nitration in vivo and its impact on IRP-1 functions. J. Biol. Chem. 279 (2004) 43345-43351
190. Nairz M., Fritsche G., Brunner P., Talasz H., Hantke K., and Weiss G. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immun. 38 (2008) 1923-1936
191. Peyssonnaux C., Zinkernagel A.S., Datta V., Lauth X., Johnson R.S., and Nizet V. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood 107 (2006) 3727-3732
192. Liu X.B., Nguyen N.B., Marquess K.D., Yang F., and Haile D.J. Regulation of hepcidin and ferroportin expression by lipopolysaccharide in splenic macrophages. Blood Cells Mol. Dis. 35 (2005) 47-56
193. Theurl I., Theurl M., Seifert M., Mair S., Nairz M., Rumpold H., Zoller H., Bellmann-Weiler R., Niederegger H., Talasz H., and Weiss G. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111 (2008) 2392-2399
194. Nguyen N.B., Callaghan K.D., Ghio A.J., Haile D.J., and Yang F. Hepcidin expression and iron transport in alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L417-425
195. Pietrangelo A., Dierssen U., Valli L., Garuti C., Rump A., Corradini E., Ernst M., Klein C., and Trautwein C. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132 (2007) 294-300
196. Verga Falzacappa M.V., Vujic Spasic M., Kessler R., Stolte J., Hentze M.W., and Muckenthaler M.U. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109 (2007) 353-358
197. Wrighting D.M., and Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 108 (2006) 3204-3209
198. Sow F.B., Florence W.C., Satoskar A.R., Schlesinger L.S., Zwilling B.S., and Lafuse W.P. Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J. Leukoc. Biol. 82 (2007) 934-945
199. Weiss G., Bogdan C., and Hentze M.W. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J. Immunol. 158 (1997) 420-425
200. Tilg H., Ulmer H., Kaser A., and Weiss G. Role of IL-10 for induction of anemia during inflammation. J. Immunol. 169 (2002) 2204-2209
201. Lee T.S., and Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8 (2002) 240-246
202. Pioli P.A., Goonan K.E., Wardwell K., and Guyre P.M. TGF-beta regulation of human macrophage scavenger receptor CD163 is Smad3-dependent. J. Leukoc. Biol. 76 (2004) 500-508
203. Loreal O., and Brissot P. [Hepcidin: small molecule, large future]. Rev. Med. Interne. 24 (2003) 213-215
204. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
205. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110 (2002) 1037-1044
206. Fleming R.E., and Sly W.S. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8160-8162
207. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 (2004) 1271-1276
208. Flanagan J.M., Truksa J., Peng H., Lee P., and Beutler E. In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol. Dis. 38 (2007) 253-257
209. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., and Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
210. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1906-1910
211. Constante M., Wang D., Raymond V.A., Bilodeau M., and Santos M.M. Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha. Am. J. Pathol. 170 (2007) 497-504
212. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., Rankin E., Vaulont S., Haase V.H., Nizet V., and Johnson R.S. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 117 (2007) 1926-1932
213. Yoon D., Pastore Y.D., Divoky V., Liu E., Mlodnicka A.E., Rainey K., Ponka P., Semenza G.L., Schumacher A., and Prchal J.T. Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J. Biol. Chem. 281 (2006) 25703-25711
214. Babitt J.L., Huang F.W., Xia Y., Sidis Y., Andrews N.C., and Lin H.Y. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117 (2007) 1933-1939
215. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., Campagna J.A., Chung R.T., Schneyer A.L., Woolf C.J., Andrews N.C., and Lin H.Y. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38 (2006) 531-539
216. Silvestri L., Pagani A., and Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 111 (2008) 924-931
217. De Domenico I., Ward D.M., and Kaplan J. Hepcidin regulation: ironing out the details. J. Clin. Invest. 117 (2007) 1755-1758
218. Nicolas G., Viatte L., Bennoun M., Beaumont C., Kahn A., and Vaulont S. Hepcidin, a new iron regulatory peptide. Blood Cells Mol. Dis. 29 (2002) 327-335
219. Pinto J.P., Ribeiro S., Pontes H., Thowfeequ S., Tosh D., Carvalho F., and Porto G. Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signalling and regulation of C/EBP{alpha}. Blood 111 (2008) 5727-5733
220. Braliou G.G., Verga Falzacappa M.V., Chachami G., Casanovas G., Muckenthaler M.U., and Simos G. 2-Oxoglutarate-dependent oxygenases control hepcidin gene expression. J. Hepatol. 48 (2008) 801-810
221. Wang J., Chen G., Muckenthaler M., Galy B., Hentze M.W., and Pantopoulos K. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell Biol. 24 (2004) 954-965
222. Tacchini L., Gammella E., De Ponti C., Recalcati S., and Cairo G. Role of HIF-1 and NF-{kappa}B transcription factors in the modulation of transferrin receptor by inflammatory and anti-inflammatory signals. J. Biol. Chem. 283 (2008) 20674-20686
223. Fraenkel P.G., Traver D., Donovan A., Zahrieh D., and Zon L.I. Ferroportin1 is required for normal iron cycling in zebrafish. J. Clin. Invest. 115 (2005) 1532-1541
224. Liu S., Suragani R.N., Wang F., Han A., Zhao W., Andrews N.C., and Chen J.J. The function of heme-regulated eIF2alpha kinase in murine iron homeostasis and macrophage maturation. J. Clin. Invest. 117 (2007) 3296-3305
225. Chen J.J. Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias. Blood 109 (2007) 2693-2699
226. Angelillo-Scherrer A., Burnier L., Lambrechts D., Fish R.J., Tjwa M., Plaisance S., Sugamele R., DeMol M., Martinez-Soria E., Maxwell P.H., Lemke G., Goff S.P., Matsushima G.K., Earp H.S., Chanson M., Collen D., Izui S., Schapira M., Conway E.M., and Carmeliet P. Role of Gas6 in erythropoiesis and anemia in mice. J. Clin. Invest. 118 (2008) 583-596
227. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
228. Finch C. Regulators of iron balance in humans. Blood 84 (1994) 1697-1702
229. Tanno T., Bhanu N.V., Oneal P.A., Goh S.H., Staker P., Lee Y.T., Moroney J.W., Reed C.H., Luban N.L., Wang R.H., Eling T.E., Childs R., Ganz T., Leitman S.F., Fucharoen S., and Miller J.L. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat. Med. 13 (2007) 1096-1101
230. Collins A.J., Ma J.Z., and Ebben J. Impact of hematocrit on morbidity and mortality. Semin. Nephrol. 20 (2000) 345-349
231. Weinberg E.D. The role of iron in cancer. Eur. J. Cancer Prev. 5 (1996) 19-36
232. Schrettl M., Bignell E., Kragl C., Joechl C., Rogers T., Arst Jr. H.N., Haynes K., and Haas H. Siderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulence. J. Exp. Med. 200 (2004) 1213-1219
233. Boyer E., Bergevin I., Malo D., Gros P., and Cellier M.F. Acquisition of Mn(II) in addition to Fe(II) is required for full virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 70 (2002) 6032-6042
234. Kontoghiorghes G.J., and Weinberg E.D. Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Rev. 9 (1995) 33-45
235. Hantke K. Iron and metal regulation in bacteria. Curr. Opin. Microbiol. 4 (2001) 172-177
236. Flo T.H., Smith K.D., Sato S., Rodriguez D.J., Holmes M.A., Strong R.K., Akira S., and Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432 (2004) 917-921
237. Fluckinger M., Haas H., Merschak P., Glasgow B.J., and Redl B. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob. Agents Chemother. 48 (2004) 3367-3372
238. Berger T., Togawa A., Duncan G.S., Elia A.J., You-Ten A., Wakeham A., Fong H.E., Cheung C.C., and Mak T.W. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1834-1839
239. Devireddy L.R., Gazin C., Zhu X., and Green M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123 (2005) 1293-1305
240. Nairz M., Theurl I., Ludwiczek S., Theurl M., Mair S.M., Fritsche G., and Weiss G. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol. 9 (2007) 2126-2140
241. Olakanmi O., Schlesinger L.S., Ahmed A., and Britigan B.E. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. J. Biol. Chem. 277 (2002) 49727-49734
242. Barton C.H., Whitehead S.H., and Blackwell J.M. Nramp transfection transfers Ity/Lsh/Bcg-related pleiotropic effects on macrophage activation: influence on oxidative burst and nitric oxide pathways. Mol. Med. 1 (1995) 267-279
243. Chlosta S., Fishman D.S., Harrington L., Johnson E.E., Knutson M.D., Wessling-Resnick M., and Cherayil B.J. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 74 (2006) 3065-3067
244. Weiss G., Wachter H., and Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol. Today 16 (1995) 495-500
245. Weiss G., Fuchs D., Hausen A., Reibnegger G., Werner E.R., Werner-Felmayer G., and Wachter H. Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp. Hematol. 20 (1992) 605-610
246. Oexle H., Kaser A., Most J., Bellmann-Weiler R., Werner E.R., Werner-Felmayer G., and Weiss G. Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J. Leukoc. Biol. 74 (2003) 287-294
247. Recalcati S., Pometta R., Levi S., Conte D., and Cairo G. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood 91 (1998) 2565-2572
248. Mencacci A., Cenci E., Boelaert J.R., Bucci P., Mosci P., Fe d'Ostiani C., Bistoni F., and Romani L. Iron overload alters innate and T helper cell responses to Candida albicans in mice. J. Infect. Dis. 175 (1997) 1467-1476
249. Fritsche G., Larcher C., Schennach H., and Weiss G. Regulatory interactions between iron and nitric oxide metabolism for immune defense against Plasmodium falciparum infection. J. Infect. Dis. 183 (2001) 1388-1394
250. Boelaert J.R., Vandecasteele S.J., Appelberg R., and Gordeuk V.R. The effect of the host's iron status on tuberculosis. J. Infect. Dis. 195 (2007) 1745-1753
251. Bogdan C. Nitric oxide and the immune response. Nat. Immunol. 2 (2001) 907-916
252. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15 (1997) 323-350
253. Melillo G., Taylor L.S., Brooks A., Musso T., Cox G.W., and Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272 (1997) 12236-12243
254. Weiss G., Werner-Felmayer G., Werner E.R., Grunewald K., Wachter H., and Hentze M.W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180 (1994) 969-976
255. Dlaska M., and Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162 (1999) 6171-6177
256. Weiss G., Thuma P.E., Mabeza G., Werner E.R., Herold M., and Gordeuk V.R. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J. Infect. Dis. 175 (1997) 226-230
257. Patruta S.I., Edlinger R., Sunder-Plassmann G., and Horl W.H. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J. Am. Soc. Nephrol. 9 (1998) 655-663
258. Omara F.O., and Blakley B.R. The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse. Br. J. Nutr. 72 (1994) 899-909
259. Collins H.L., Kaufmann S.H., and Schaible U.E. Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst. J. Immunol. 168 (2002) 3458-3463
260. Figueiredo R.T., Fernandez P.L., Mourao-Sa D.S., Porto B.N., Dutra F.F., Alves L.S., Oliveira M.F., Oliveira P.L., Graca-Souza A.V., and Bozza M.T. Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282 (2007) 20221-20229
261. Iannotti L.L., Tielsch J.M., Black M.M., and Black R.E. Iron supplementation in early childhood: health benefits and risks. Am. J. Clin. Nutr. 84 (2006) 1261-1276
262. Gordeuk V., Thuma P., Brittenham G., McLaren C., Parry D., Backenstose A., Biemba G., Msiska R., Holmes L., McKinley E., et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327 (1992) 1473-1477
263. Thuma P.E., Weiss G., Herold M., and Gordeuk V.R. Serum neopterin, interleukin-4, and interleukin-6 concentrations in cerebral malaria patients and the effect of iron chelation therapy. Am. J. Trop. Med. Hyg. 54 (1996) 164-168
264. Thuma P.E., Mabeza G.F., Biemba G., Bhat G.J., McLaren C.E., Moyo V.M., Zulu S., Khumalo H., Mabeza P., M'Hango A., Parry D., Poltera A.A., Brittenham G.M., and Gordeuk V.R. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans. R. Soc. Trop. Med. Hyg. 92 (1998) 214-218
265. V.R. Gordeuk, A. Caleffi, E. Corradini, F. Ferrara, R.A. Jones, O. Castro, O. Onyekwere, R. Kittles, E. Pignatti, G. Montosi, C. Garuti, I.T. Gangaidzo, Z.A. Gomo, V.M. Moyo, T.A. Rouault, P. MacPhail, A. Pietrangelo, Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene small star, filled, Blood Cells Mol. Dis. 31 (2003) 299-304.
266. Gordeuk V.R. African iron overload. Semin. Hematol. 39 (2002) 263-269
267. Schnappinger D., Ehrt S., Voskuil M.I., Liu Y., Mangan J.A., Monahan I.M., Dolganov G., Efron B., Butcher P.D., Nathan C., and Schoolnik G.K. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198 (2003) 693-704
268. Appelberg R. Macrophage nutriprive antimicrobial mechanisms. J. Leukoc. Biol. 79 (2006) 1117-1128
269. Weiss G., and Gordeuk V.R. Benefits and risks of iron therapy for chronic anaemias. Eur. J. Clin. Invest. 35 Suppl. 3 (2005) 36-45